Novo Nordisk says Wegovy heart benefits due to more than weight loss
/cloudfront-us-east-2.images.arcpublishing.com/reuters/7XXQIDEIWRKN3NZA62CUCEHSMM.jpg)
A 0.25 mg injection pen of Novo Nordisk’s weight-loss drug Wegovy is shown in this photo illustration in Oslo, Norway, September 1, 2023. REUTERS/Victoria Klesty/Illustration/File Photo Acquire Licensing Rights PHILADELPHIA, Nov 11 (Reuters) – Novo Nordisk (NOVOb.CO) on Saturday said the heart protective benefits of its wildly popular Wegovy obesity treatment are due to more … Read more